Singapore, Oct. 8 -- Andelyn Biosciences ("Andelyn"), a leading US-based patient-focused cell and gene therapy Contract Development and Manufacturing Organization ("CDMO"), and PQP Group announced a strategic partnership.

PQP, headquartered in the UK and the Netherlands, holds Manufacturing and Import Authorizations and provides Qualified Person (QP) services that enable clients to import and release medicinal products from outside these territories, supporting Clinical Trial Authorizations (CTAs) and related supply.

Through the partnership, Andelyn and PQP are expanding support for sponsors supplying cell and gene therapy products to clinical sites in the EU and UK. The relationship establishes a standard process to support sponsors in...